Product Information
- 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-thieno[2,3-d]pyrimidine
Applications MI-3 (Menin-MLL Inhibitor) reverses oncogenic activity of MLL fusion proteins in leukemia.
References Grembecka, J. et al.: Nat. Chem. Biol., 8, 277 (2012);
Chemical properties
Technical inquiry about: TR-M341040 MI-3 (Menin-MLL Inhibitor)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.